Weak Growth in Financial Stocks: Several financial sector stocks, including DeFi Technologies Inc., Pathfinder Bancorp Inc., and GoHealth Inc., are struggling with low growth in revenue and earnings, placing them among the weakest performers in their category.
Significant Declines Noted: DeFi Technologies saw a drastic drop in its growth ranking from 62.95 to 9.98, while Pathfinder Bancorp and GoHealth also experienced severe declines, indicating ongoing challenges in sustaining growth.
Performance Overview: Carver Bancorp and LM Funding America showed slight improvements but remain in the lowest growth percentiles, with both companies experiencing significant year-to-date stock price declines.
Investor Implications: The weak growth profiles of these companies highlight structural challenges within the financial sector, which may negatively impact their valuation outlooks as investors favor stocks with visible momentum.
Wall Street analysts forecast GOCO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for GOCO is 11.00 USD with a low forecast of 10.00 USD and a high forecast of 12.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Analyst Rating
Wall Street analysts forecast GOCO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for GOCO is 11.00 USD with a low forecast of 10.00 USD and a high forecast of 12.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
2 Hold
0 Sell
Moderate Buy
Current: 2.400
Low
10.00
Averages
11.00
High
12.00
Current: 2.400
Low
10.00
Averages
11.00
High
12.00
RBC Capital
Sector Perform
downgrade
$12 -> $5
Al Analysis
2025-11-26
Reason
RBC Capital
Price Target
$12 -> $5
Al Analysis
2025-11-26
downgrade
Sector Perform
Reason
RBC Capital lowered the firm's price target on GoHealth to $5 from $12 and keeps a Sector Perform rating on the shares. The firm is updating its model following the company's Q3 results, which came in significantly below expectations due to topline weakness as a result of one large carrier suspending its relationship with, the analyst tells investors in a research note.
William Blair
Outperform -> Market Perform
downgrade
2025-11-18
Reason
William Blair
Price Target
2025-11-18
downgrade
Outperform -> Market Perform
Reason
William Blair downgraded GoHealth to Market Perform from Outperform.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for GOCO
Unlock Now
William Blair
William Blair
Outperform -> Market Perform
downgrade
2025-11-18
Reason
William Blair
William Blair
Price Target
2025-11-18
downgrade
Outperform -> Market Perform
Reason
William Blair downgraded GoHealth to Market Perform from Outperform. Q3 revenue and Medicare submissions were below the firm's expectations as the company pulled back on new enrollment growth, aligning with insurer actions to prioritize profitability and member retention over board member expansion, the analyst tells investors in a research note. The firm added that it believes the decision to limit cash burn is prudent given he challenging market dynamic, though it downgrades the shares given market headwinds that will likely persist through 2026,unccertatinty on GoHealth's ability to generate sustainable positive cash flow, and limited progress in diversifying its business model.
Noble Capital
Patrick McCann
Outperform
downgrade
$20 -> $10
2025-11-14
Reason
Noble Capital
Patrick McCann
Price Target
$20 -> $10
2025-11-14
downgrade
Outperform
Reason
Noble Capital analyst Patrick McCann lowered the firm's price target on GoHealth to $10 from $20 and keeps an Outperform rating on the shares. Q3 results came in below expectations and management expects the current environment to last several quarters as carriers recalibrate benefit structures and cost models, notes the analyst, whose Q4 and 2026 forecasts are now "materially lower than our previous estimates." However, the firm believes the long-term revenue and margin potential remain attractive once the Medicare Advantage market stabilizes, the analyst tells investors.
About GOCO
GoHealth, Inc. is a medicare-focused digital health company that operates in a health insurance marketplace. The Company primarily offers Medicare plans, including Medicare Advantage, Medicare Supplement and prescription drug plans. Its technology platform leverages modern machine-learning algorithms, powered by insurance purchasing behavior, to reimagine the process of matching a health plan to a consumer’s specific needs. Its Medicare Advantage offerings include Special Needs Plans (SNPs). SNPs are special kinds of Medicare Advantage plans that have benefits covering special health care or financial needs. Its Marketplace technology features decision support tools and integrates with health plan partner enterprise systems, enabling agents to quickly select the right health insurance plan for each consumer based on their specific needs and enroll them in those plans. It offers Encompass Connect and Encompass Engage services to its health plan partners.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
